Increased technetium-99m-GSA uptake per hepatocyte in rats with administration of dimethylnitrosamine or hepatocyte growth factor

Journal of Nuclear Medicine

Volumn 39, Issue 8 SUPPL., 1998, Pages 1463-1467

  Kouda, Katsuyasu ^a,b   Ha Kawa, Sang Kil ^a,b   Tanaka, Yoshimasa ^a,b  

^a KANSAI MEDICAL UNIVERSITY   (Japan)

^b HAMAMATSU UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Asialoglycoprotein receptors; Dimethylnitrosamine; Hepatocyte growth factor; Technetium 99m galactosyl human serum albumin

Indexed keywords

ASIALOGLYCOPROTEIN RECEPTOR; DIMETHYLNITROSAMINE; PENTETATE GALACTOSYL HUMA SERUM ALBUMIN TC 99M; RADIOPHARMACEUTICAL AGENT; SCATTER FACTOR; UNCLASSIFIED DRUG;

ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CONTROLLED STUDY; ENDOCYTOSIS; LIVER CELL; LIVER INJURY; LIVER SCINTISCANNING; MALE; NONHUMAN; PLASMA CLEARANCE; PRIORITY JOURNAL; RAT;

ALKYLATING AGENTS; ANIMALS; DIMETHYLNITROSAMINE; HEPATITIS, TOXIC; HEPATOCYTE GROWTH FACTOR; HUMANS; LIVER; MALE; RADIOPHARMACEUTICALS; RATS; RATS, SPRAGUE-DAWLEY; TECHNETIUM TC 99M AGGREGATED ALBUMIN; TECHNETIUM TC 99M PENTETATE; TIME FACTORS;

EID: 0031876152     PISSN: 01615505     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (30)

1. Morell AG, Irvine RA, Sternlieb 1. Scheinberg IH. Physical and chemical studies on ceruloplasmin. V. Metabolic studies on sialic acid-free ceruloplasmin in vivo. J Biol Clicm 1968:243:155 159.
2. lla-Kawa SK, Tanaka Y. A quantitative model of iechnetium-99m-DTPA-galactosylHSA for the assessment of hepatic blood flow and hepatic binding receptor. J Nucl \h-ti 1991:32:2233-2240.
3. (ialli Ci, Maini CI, Orlando P. Dcleide G, Valle G. A radiophannaceutical for the study of the liver: '''''Tc-DTPA-asialo-orosoniucoid. I. Radiochcmical and animal distribution studies. Nucl Med Allied Sei 1988;32:l 10-1 16.
4. Galli G. Maini CL, Orlando P. et al. A radiophannaceutical for the study of the liver: ''''Tc-DTPA-asialo-orosomucoid. II. Human dynamic and imaging studies. Nitcl \h'd Allied Sri 1988;32:117-126.
5. Ashwell G. Steer CJ. Hepatic recognition and catabolism of serum glycoprotcins. JAMA 1981:246:2358 2364.
6. Stocken RJ. Morcll AG. Hepatic binding protein: the galactose-specific receptor of mammalian hepatocytes. Ilepaiologv 1983:3:750-757.
7. Sawamura T, Kawasato S, Siozaki Y. Sameshima Y, Nakada H. Tashiro Y. Decrease of a hepatic binding protein specific for asialoglycoproteins with accumulation of serum asialoglycoproteins in galactosamine-treated rats. Gastroenterologe 1981:81: 527-533.
8. Sawamura T. Nakada H, Hazama H. Shiozaki Y. Sameshima Y. Tashiro Y. Hyperasialoglycoproteinemia in patients with chronic liver diseases and/or liver cell carcinoma: asialoglycoprotein receptor in cirrhosis and liver cell carcinoma. Gastroentero/iigy 1984:87:1217-1221.
9. Appel M. Potrat P. Feger J, Mas-Chamberlin C, Durand G. In vivo quantification of removal of asialo-orosomucoid from the circulation in anaesthetized streptozotocindiabetic rats. Diabetologia 1986:29:383-387.
10. Dodeur M, Durand D, Dumont J. Durand G, Feger J, Agneray J. Effects of streptozotocin-induced diabetes mellitus on the binding and uptake of asialoorosomucoid by isolated hepatocytes from rats. EurJ Biochem 1982:123:383-387.
11. Howard D.I. Stocken RJ. Morell AG. Asialoglycoprotein receptors in hepatic regeneration. J Binl Chem 1982:257:2856-2858.
12. Fworek BL, Tuma DJ. Casey C'A. Decreased binding of asialoglycoproteins to hepatocytes from ethanol-fed rats. J Biol Chem 1996:271:2531-2538.
13. Wanson JC, Bernaert D, May C, Deschuyteneer M, Prieels JP. Isolation and culture of adult rat hepatocytes and preneoplastic nodules from diethylnitrosamine treated livers: glucose-6-phosphatase distribution, albumin synthesis and hepatic binding protein activity. Ann .V Y Acad Sei 1980:349:413 415.
14. Kinoshita T. Tashiro K. Nakamura T. Marked increase of HGF mRNA in nonparenchymal liver cells of rats treated with hepatotoxins. Biochem Biophvs Res C 'ttmmun 1989:165:1229-1234.
15. Hamanoue M. Kawaida K, Takao S. et al. Rapid and marked induction of hepalocyte growth factor during liver regeneration after ischémie or crush injury-. Hepalologv 1992:16:1485-1492.
16. Gohda E. Tsubouchi H, Nakayama H. et al. Purification and partial characterization of hepatocyte growth factor from plasma of a patient with fulminant hepatic failure. J Clin Invest 1988:81:414 419.
17. Miyazawa K. Tsubouchi H. Naka D. et al. Molecular cloning and sequence analysis of cDNA for human hepatocyte growth factor. Biochem Biophys Res Commun 1989:163: 967 973.
18. Nakamura T. Nishizawa T, Hagiya M. et al. Molecular cloning and expression of human hepatocyte growth factor. Nature 1989:342:440-443.
19. Y'oshiyama Y. Arakaki N. Naka D, et al. Identification of the N-terminal residue of the heavy chain of both native and recombinant human hepatocyte growth factor. Biochem Biophys Rex Commun 1991:175:660-667.
20. Strain AJ. Ismail T. Tsubouchi H. et al. Native and recombinant human hepatocyte growth factors are highly potent promoters of DNA synthesis in both human and rat hepatocytes.J Clin Invest 1991:87:1853 1857.
21. Ishii T. Sato M, Sudo K. et al. Hepatoeyte growth factor stimulates liver regeneration and elevates blood protein level in normal and partially hepatectomizcd rats. J Biochem 1995:117:1105-1112.
22. Jézequel AM. Mancini R. Rinaldcsi ML, Macarri G. Venturini C, Orlandi F. A morphological study of the early stages of hepatic fibrosis induced by low doses of dimcthylnitrosaminc in the rat. J He/Hitol 1987:5:174-181.
23. Okamoto K. Sugie S, Ohnisi M, et al. C'hemopreventive effects of taurine on diethylnitrosamine and phenobarbital-induced hepatocarcinogenesis in male F344 rats. .Ipn J Cancer Res 1996:87:30-36.
24. Gates G A. Henley KS, Pollard HM, Schmidt E, Schmidt FW. The cell population of human liver. J Lab Clin Med 1961:57:182-184.
25. Bûcher NI.R. Experimental aspects of hepatic regeneration. .V Engl J Med 1967:277: 686 -696.
26. Bucher NER. Experimental aspects of hepatic regeneration (concluded). .V Engl J \fad 1967:277:738-746.
27. Ryoo JW. Buschmann RJ. A morphomctric analysis of the hypertrophy of experimental liver cirrhosis. Yin-horn Arch [A] 1983:400:173 186.
28. Hildcbrand R. Nuclear volume and cellular metabolism. Ad\ Anal Embrvol Cell Biol 1980:60:1 54.
29. Fujiwara K. Nagoshi S, Ohno A, et al. Stimulation of liver growth by exogeneous human hepatocyte growth factor in normal and partially hepateclomized rats. HepatoloKy 1993:18:1443-1449.
30. Matsuda Y. Matsumoto K, Ichida T. et al. Hepatocyte growth factor suppresses the onset of liver cirrhosis and abrogates lethal hepatic dysfunction in rats. J Biochem 1995:118:643 649.